Combinational Diuretics in Heart Failure
- 9 April 2024
- journal article
- review article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 21 (4) , 1-11
Abstract
Purpose of Review Diuretics are the cornerstone therapy for acute heart failure (HF) and congestion. Patients chronically exposed to loop diuretics may develop diuretic resistance as a consequence of nephron remodelling, and the combination of diuretics will be necessary to improve diuretic response and achieve decongestion. This review integrates data from recent research and offers a practical approach to current pharmacologic therapies to manage congestion in HF with a focus on combinational therapy. Recent Findings Until recently, combined diuretic treatment was based on observational studies and expert opinion. Recent evidence from clinical trials has shown that combined diuretic treatment can be started earlier without escalating the doses of loop diuretics with an adequate safety profile. Summary Diuretic combination is a promising strategy for overcoming diuretic resistance in HF. Further studies aiming to get more insights into the pathophysiology of diuretic resistance and large clinical trials confirming the safety and efficacy over standard diuretics regimens are warranted.Keywords
This publication has 48 references indexed in Scilit:
- Design and Baseline Characteristics of SALT-HF Trial: Hypertonic Saline Therapy in Ambulatory Heart FailureESC Heart Failure, 2024
- The Blunted Loop Diuretic Response in Acute Heart Failure is Driven by Reduced Tubular Responsiveness Rather than Insufficient Tubular Delivery. The Role of Furosemide Urine Excretion on Diuretic and Natriuretic Response in Acute Heart FailureEuropean Journal of Heart Failure, 2023
- Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart FailureJAMA, 2023
- Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of CardiologyEuropean Journal of Heart Failure, 2022
- Dose of Furosemide Before Admission Predicts Diuretic Efficiency and Long-Term Prognosis in Acute Heart FailureESC Heart Failure, 2021
- Epidemiology of Heart FailureEuropean Journal of Heart Failure, 2020
- Randomized, Double-Blind, Placebo-Controlled, Multicentre Pilot Study on the Effects of Empagliflozin on Clinical Outcomes in Patients with Acute Decompensated Heart Failure (EMPA-RESPONSE-AHF)European Journal of Heart Failure, 2020
- The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2019
- Benefit of Tolvaptan in the Management of Hyponatraemia in Patients with Diuretic-Refractory Congestive Heart Failure: The SEMI-SEC ProjectESC Heart Failure, 2017
- Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart FailureThe EVEREST Outcome TrialJAMA, 2007